title: The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
abstract: Insulin resistance and hyperinsulinemia play important roles in the pathogenesis of polycystic ovary syndrome (PCOS). In addition, some women with PCOS have been shown to have insulin secretory defects and can be predicted to be at an increased risk for glucose intolerance. We performed the present study to determine the prevalence and risk factors for glucose intolerance in Korean women with PCOS. We consecutively recruited 194 women with PCOS diagnosed by American Society for Reproductive Medicine/European Society of Human Reproduction and Embryology (ASRM/ESHRE) criteria. Anthropometric measures, 75 g oral glucose tolerance test (OGTT), and measurement of insulin sensitivity (insulin mediated glucose uptake; IMGU) using euglycemic hyperinsulinemic clamp technique were performed. In women with PCOS, the prevalence of impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) was 17.0% and type 2 diabetes 1.0%, and in lean women with PCOS, the prevalence of IGT and/or IFG was 5.9%. The prevalence of glucose intolerance was 28-fold higher in women with PCOS, and 9.8-fold higher in lean women with PCOS compared to age-matched Korean women. Women with glucose intolerance had higher BMI, waist circumference, free testosterone, fasting insulin, 2-h post-load insulin, total cholesterol, LDL cholesterol, triglyceride and lower sex hormone binding globulin and IMGU than women with normal glucose tolerance (NGT) (P < 0.05). IMGU was the most powerful predictor for glucose intolerance after adjustment for age, BMI, waist circumference, and hyperandrogenemia. The 2-h OGTT was the best screening measure for glucose intolerance and diagnosis of diabetes in women with PCOS. Young Korean women with PCOS have high prevalence for glucose intolerance and type 2 diabetes, and insulin resistance is the most important factor associated with glucose intolerance.
authors.affiliation: Department of Internal Medicine, School of Medicine, Mokdong Hospital, Ewha Womans University, Mok 6-dong, Yangcheon-gu, Seoul, Korea. hyejinlee@ewha.ac.kr
authors.forename: Hyejin
authors.initials: H
authors.lastname: Lee
authors.forename: Jee-Young
authors.initials: JY
authors.lastname: Oh
authors.forename: Yeon-Ah
authors.initials: YA
authors.lastname: Sung
authors.forename: Hyewon
authors.initials: H
authors.lastname: Chung
authors.forename: Wha Young
authors.initials: WY
authors.lastname: Cho
mesh_terms: D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D005260:Female; D018149:Glucose Intolerance / Q000453:epidemiology* / Q000209:etiology*; D006801:Humans; D007723:Korea / Q000453:epidemiology; D009765:Obesity / Q000150:complications / Q000453:epidemiology; D016017:Odds Ratio; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000150:complications / Q000453:epidemiology* / Q000378:metabolism; D015995:Prevalence; D012307:Risk Factors; D013739:Testosterone / Q000097:blood; D055105:Waist Circumference; D055815:Young Adult
chemical_list: D001786:Blood Glucose; D013739:Testosterone
references.citation: Lancet. 2004 Jan 10;363(9403):157-63
references.pmid: 14726171
references.citation: J Clin Endocrinol Metab. 1994 May;78(5):1052-8
references.pmid: 8175959
references.citation: Hum Reprod. 2002 Jan;17(1):76-82
references.pmid: 11756365
references.citation: Am J Physiol. 1979 Sep;237(3):E214-23
references.pmid: 382871
references.citation: J Clin Endocrinol Metab. 2004 Jun;89(6):2942-5
references.pmid: 15181081
references.citation: J Clin Endocrinol Metab. 1993 Dec;77(6):1636-40
references.pmid: 8263152
references.citation: Clin Chem Lab Med. 2007;45(5):639-44
references.pmid: 17484627
references.citation: Int J Gynaecol Obstet. 2001 Nov;75(2):177-84
references.pmid: 11684113
references.citation: Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S233-7
references.pmid: 17606307
references.citation: J Nutr. 2002 Sep;132(9):2574-9
references.pmid: 12221211
references.citation: J Clin Endocrinol Metab. 1999 Jan;84(1):165-9
references.pmid: 9920077
references.citation: Diabetes. 2004 Sep;53(9):2353-8
references.pmid: 15331545
references.citation: Diabetes Care. 2007 Jan;30 Suppl 1:S4-S41
references.pmid: 17192377
references.citation: Fertil Steril. 2009 May;91(5):1864-8
references.pmid: 18565519
references.citation: Fertil Steril. 2004 Jan;81(1):19-25
references.pmid: 14711538
references.citation: Horm Res. 2001;55(2):65-70
references.pmid: 11509861
references.citation: Acta Obstet Gynecol Scand. 2005 Dec;84(12):1192-6
references.pmid: 16305707
references.citation: Int J Impot Res. 2005 May-Jun;17(3):259-63
references.pmid: 15616608
references.citation: Diabetes. 1989 Sep;38(9):1165-74
references.pmid: 2670645
references.citation: Diabetes Care. 1999 Jan;22(1):141-6
references.pmid: 10333916
references.citation: Annu Rev Med. 2001;52:401-19
references.pmid: 11160786
references.citation: J Clin Endocrinol Metab. 1999 Jul;84(7):2329-35
references.pmid: 10404798
references.citation: N Engl J Med. 1993 Dec 30;329(27):1988-92
references.pmid: 8247074
references.citation: Diabetes Care. 2004 Aug;27(8):2027-32
references.pmid: 15277435
references.citation: Eur J Endocrinol. 2006 Feb;154(2):295-301
references.pmid: 16452544
references.citation: Endocr Rev. 1997 Dec;18(6):774-800
references.pmid: 9408743
references.citation: Hum Reprod. 2006 Aug;21(8):2027-32
references.pmid: 16684838
references.citation: J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
references.pmid: 10523012